A mother and father’s genes play a significant role in their baby’s development; from growth in the womb, to blood type. From pregnancy through to their adult life, your child’s blood type is one of the most important pieces of genetic information to be aware of.
While we are all united in the fight against coronavirus (or COVID-19), there are many questions arising from expectant mothers about how the virus could affect pregnancy and cord blood banking. To keep you safe and in-the-know, we have compiled some of the most commonly asked questions and answers on these important topics.
A three-year-old girl has received treatment for cerebral palsy (CP), using her baby brother’s cord blood stem cells. The sample was taken from their mother’s umbilical cord at birth and stored with Future Health Biobank, at our Swiss storage facility.
Scientists at Future Health Biobank have provided samples of umbilical cord mesenchymal stem cells (MSCs), to aid pioneering research into the regeneration of tooth dentin and bone.
A recent BBC article has shone a spotlight on the “massively misdiagnosed” 22q deletion syndrome. This genetic condition can cause a range of mild to severe behavioural, psychological and physical symptoms, but often flies under the radar in babies and children.
Bern, Switzerland - September 6-7, 2018 Conference Report:
The International Stem Cell Conference / International Placenta Stem Cell Society Conference took place in Bern, Switzerland between the 6 and 7 September 2018. More than 27 presentations with speakers arriving from the USA, Australia, New Zealand, Israel, Russia, France, UK, Ukraine, Sweden, Austria, Italy, Spain and from across different universities within Switzerland.
As more and more research highlights the benefits of delayed cord clamping, it’s understandable that umbilical cord blood stem cell banking raises many questions for parents-to-be. Here we explain how delayed cord clamping works alongside cord blood stem cell banking to help protect your baby’s health.
